Boston Scientific (BSX)
$42.15 0.28 (0.67%)
18:29 EDT BSX Stock Quote Delayed 15 Minutes
Previous Close $42.15
Market Cap 58.16B
PE Ratio 526.88
Volume (Avg. Vol.) 3.27M
Day's Range 41.87 - 42.42
52-Week Range 31.56 - 43.66
Dividend & Yield N/A (N/A)
BSX Stock Predictions, Articles, and Boston Scientific News
- From InvestorPlace
- From the Web
TerraForm Power, Zillow Group and Boston Scientific are just some of the top stocks to buy as May turns into June.
The stock charts of HPE, CNC and BSX are going to get the new trading week started on the verge of major moves.
We have been managing a position in Boston Scientific (NYSE:BSX) since early mid-February of this year. BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
We are opening a new bullish trade on Boston Scientific (NYSE:BSX). BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
The stock charts of BSX, MDLZ and FE are at make-or-break points as of Wednesday's close. Here's what you should focus on.
The stock charts of GPS, CNP and BSX are set to get the new trading week started on a narrow path. Here's what to watch.
Take a break from the market madness with some killer dividend stocks. All 7 of these high-yield stocks also have a “Strong Buy” consensus
I am bullish on BSX stock for the long-term. However, I don’t know that right now is the right time to buy Boston Scientific.
The stock charts of ZION, BSX and WU are your top prospects headed into today's trading action.
ROE is often used to compare the profitability of a company with other firms in the industry – the higher, the better. Compare Brokers....
The Glassdoor Top CEOs 2018 list is now up and 'InvestorPlace' is taking a look at the top 10 CEOs that made it onto the list.
Growth at a reasonable price or the GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. Compare....
Boston Scientific (BSX) stock was soaring Monday on talk of a possible takeover by Stryker (SYK), but details are still scarce.
From Analyst Ratings
Yesterday, the SVP, Manuf & Sup Chn of Boston Scientific Corp (BSX – Research Report), John Bradley Sorenson, sold shares of BSX for $256.7K. Following John Bradley Sorenson’s last BSX Sell transaction on August 04, 2017, the stock climbed by 14.6%. See today’s analyst top recommended stocks >> Based on Boston Scientific Corp’s latest earnings
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!